vs
Gossamer Bio, Inc.（GOSS）与KKR Real Estate Finance Trust Inc.（KREF）财务数据对比。点击上方公司名可切换其他公司
KKR Real Estate Finance Trust Inc.的季度营收约是Gossamer Bio, Inc.的1.9倍（$25.8M vs $13.8M），KKR Real Estate Finance Trust Inc.净利率更高（-101.7% vs -342.3%，领先240.6%），Gossamer Bio, Inc.同比增速更快（47.1% vs -26.6%）
Gossamer Bio是一家临床阶段生物制药企业，专注于发现、开发和商业化用于治疗免疫、炎症和肿瘤领域重症疾病的创新疗法，推进多条自研候选药物管线进入不同临床阶段，主要面向北美及全球其他地区的医疗市场。
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
GOSS vs KREF — 直观对比
营收规模更大
KREF
是对方的1.9倍
$13.8M
营收增速更快
GOSS
高出73.7%
-26.6%
净利率更高
KREF
高出240.6%
-342.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.8M | $25.8M |
| 净利润 | $-47.2M | $-26.2M |
| 毛利率 | — | — |
| 营业利润率 | -333.6% | -105.1% |
| 净利率 | -342.3% | -101.7% |
| 营收同比 | 47.1% | -26.6% |
| 净利润同比 | -43.0% | -229.6% |
| 每股收益（稀释后） | $-0.21 | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GOSSKREF
| Q4 25 | $13.8M | $25.8M | ||
| Q3 25 | $13.3M | $25.3M | ||
| Q2 25 | — | $30.2M | ||
| Q1 25 | — | $31.3M | ||
| Q4 24 | — | $35.1M | ||
| Q3 24 | — | $37.0M | ||
| Q2 24 | $95.8M | $40.4M | ||
| Q1 24 | $0 | $39.1M |
净利润GOSSKREF
| Q4 25 | $-47.2M | $-26.2M | ||
| Q3 25 | $-48.2M | $13.8M | ||
| Q2 25 | — | $-29.7M | ||
| Q1 25 | — | $-4.9M | ||
| Q4 24 | — | $20.3M | ||
| Q3 24 | — | $-7.4M | ||
| Q2 24 | $49.2M | $25.8M | ||
| Q1 24 | $-41.9M | $-3.1M |
营业利润率GOSSKREF
| Q4 25 | -333.6% | -105.1% | ||
| Q3 25 | -369.4% | 50.4% | ||
| Q2 25 | — | -101.3% | ||
| Q1 25 | — | -18.3% | ||
| Q4 24 | — | 55.8% | ||
| Q3 24 | — | -19.6% | ||
| Q2 24 | 54.3% | 63.3% | ||
| Q1 24 | — | -8.7% |
净利率GOSSKREF
| Q4 25 | -342.3% | -101.7% | ||
| Q3 25 | -362.7% | 54.4% | ||
| Q2 25 | — | -98.5% | ||
| Q1 25 | — | -15.5% | ||
| Q4 24 | — | 57.7% | ||
| Q3 24 | — | -20.0% | ||
| Q2 24 | 51.4% | 63.9% | ||
| Q1 24 | — | -7.9% |
每股收益（稀释后）GOSSKREF
| Q4 25 | $-0.21 | $-0.49 | ||
| Q3 25 | $-0.21 | $0.12 | ||
| Q2 25 | — | $-0.53 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $-0.19 | ||
| Q2 24 | $0.22 | $0.29 | ||
| Q1 24 | $-0.19 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $136.9M | $84.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-122.8M | $1.2B |
| 总资产 | $172.2M | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GOSSKREF
| Q4 25 | $136.9M | $84.6M | ||
| Q3 25 | $180.2M | $204.1M | ||
| Q2 25 | — | $107.7M | ||
| Q1 25 | — | $106.4M | ||
| Q4 24 | — | $104.9M | ||
| Q3 24 | — | $108.8M | ||
| Q2 24 | $354.5M | $107.2M | ||
| Q1 24 | $244.4M | $106.5M |
股东权益GOSSKREF
| Q4 25 | $-122.8M | $1.2B | ||
| Q3 25 | $-82.3M | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $81.5M | $1.4B | ||
| Q1 24 | $26.7M | $1.4B |
总资产GOSSKREF
| Q4 25 | $172.2M | $6.5B | ||
| Q3 25 | $208.8M | $6.5B | ||
| Q2 25 | — | $6.8B | ||
| Q1 25 | — | $6.6B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | — | $6.8B | ||
| Q2 24 | $373.4M | $7.1B | ||
| Q1 24 | $259.4M | $7.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-48.3M | $72.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GOSSKREF
| Q4 25 | $-48.3M | $72.3M | ||
| Q3 25 | $-36.2M | $18.5M | ||
| Q2 25 | — | $21.1M | ||
| Q1 25 | — | $15.9M | ||
| Q4 24 | — | $132.6M | ||
| Q3 24 | — | $49.1M | ||
| Q2 24 | $116.3M | $30.6M | ||
| Q1 24 | $-52.3M | $34.5M |
资本支出强度GOSSKREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
现金转化率GOSSKREF
| Q4 25 | — | — | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | 1.19× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
